Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter
Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared on X by Bullish, adding:
“Beautiful video. To activate this cell, you need a protein called IL-15.
Anktiva is that protein.
It is approved for a subset of bladder cancer. But it works on your immune system, and your NK cells kill all cancers regardless of the type!
Go figure!”
Bullish also shared a post by Massimo, adding:
“And guess what multiplies these Killer cells?
A drug just got approved last year called ANKTIVA Bioshield ‘Lymphocytes- stimulator’ by ImmunityBio, Inc., Pat Soon-Shiong spent the last 30 years of his life and $3B of his hard-earned money invented it. Instead of only for bladder cancer.
Hope FDA approves it for all cancer indications soon.”
Quoting Massimo‘s post:
“Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell.
Video – Alex Ritter / RitterLab”
Watch the video attached to this post.
More posts featuring Pat Soon-Shiong on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023